COTA expands clinicogenomics offering with Genomic Testing Cooperative partnership.
COTA was founded in 2011 by doctors, engineers, and data scientists to create clarity from fragmented and often-inaccessible real world data. By using our proprietary technology, advanced analytics and deep expertise to organize complex data, we provide a comprehensive picture of cancer that can be used to advance care and research. We believe that everyone touched by cancer deserves a clear path to care. Together, we can make that vision a reality.
Andrew Pecora, M.D.
Founder & Chairman
Dana Callow
Managing Partner, Boston Millenia Partners
Allen Karp
SVP, Healthcare Management, Horizon Blue Cross Blue Shield
Jonathan Morris, M.D.
VP Provider Solutions & CMIO, IQVIA
Mike Mitchell
Principal, EW Healthcare Partners
Andre Goy, M.D.
Physician in Chief at Hackensack Meridian Health Oncology Care Transformation Service, Chairman & Chief Physician Officer at John Theurer Cancer Center
Leonard Kalman, M.D.
Executive Deputy Director and Chief Medical Officer, Miami Cancer Institute, Baptist Health South Florida
Miruna Sasu
Chief Executive Officer, COTA, Inc.
Steve Wiggins
Operating Partner, EW Healthcare Partners
Mark E. Kolb
Partner, Tech Council Ventures
Rana Lonnen
Head S&E Strategic Venture Capital, Novartis
Kyle Stern
Kimberly Wilson
Executive Director of Translational Epidemiology, Informatics & Predictive Sciences, Bristol Myers Squibb
Robert Glenning
President, Financial & Information Services Divisions, CFO, Hackensack Meridian Health
Mark Coticchia
Corporate VP, Baptist Health South Florida
Rob Ciaruffoli
Vice President, Corporate Development & Venture Investments, Horizon Blue Cross Blue Shield of New Jersey
Bharath Ganesan